The Evaluation of Cow Milk-Based Formulas

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Term Infants

See also
Status	Clinical Trial	Phase
Completed	`NCT04389606` - Follow-up Study of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants	N/A
Completed	`NCT04313478` - The Relationship Between Segmental Trunk Control and Gross Motor Performance in Low Birth Weight Born Infant
Not yet recruiting	`NCT06092463` - The Intestinal Innate Immune System in Newborns. Development and Inflammation in Health and Disease

See also

Status

Clinical Trial

Phase

Completed

NCT04389606 - Follow-up Study of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants

N/A

Completed

NCT04313478 - The Relationship Between Segmental Trunk Control and Gross Motor Performance in Low Birth Weight Born Infant

Not yet recruiting

NCT06092463 - The Intestinal Innate Immune System in Newborns. Development and Inflammation in Health and Disease

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00518414
Study type	Interventional
Source	Mead Johnson Nutrition
Contact
Status	Completed
Phase	N/A
Start date	April 2007
Completion date	January 2008

The Evaluation of Cow Milk-Based Formulas

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms